A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
Novartis
Novartis
NYU Langone Health
National Institutes of Health Clinical Center (CC)
RTOG Foundation, Inc.
Advanced Accelerator Applications
Mayo Clinic
Institut Claudius Regaud
Nationwide Children's Hospital
European Organisation for Research and Treatment of Cancer - EORTC
Karolinska University Hospital
Fundación de investigación HM
University of Iowa
M.D. Anderson Cancer Center
University of Warmia and Mazury